Guardant Health valuation
$143.28Change from previous close: −0.52%Absolute change: −$0.75
Valuation
The average price target of 25 analysts is $200.76.
Data as of November 15, 2026
Guardant Health compared with similar companies
| Metric | Guardant Health | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Price/sales | 16.0 | 6.20 | 2.45 – 7.36 | High |
| Gross margin | 65.2% | 55.9% | 33.1% – 65.2% | High |
| Operating margin | -39.4% | 14.3% | 6.9% – 17.7% | Low |
| Net margin | -37.9% | 8.1% | 3.1% – 13.9% | Low |
| ROE | 171.6% | 13.4% | 3.8% – 29.6% | High |
| Debt/equity | -7.61 | 0.74 | 0.34 – 0.83 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $20.52B
- Enterprise value
- $21.19B
- P/E (trailing 12 months)
- -52.5
- Forward P/E
- -547.2
- Price/book
- -107.5
- EV/EBITDA
- -45.6
- EV/revenue
- 16.6
Profitability and growth
- ROA
- -19.9%
- ROIC
- -23.4%
- Revenue growth (year over year)
- 36.1%
- Earnings growth (year over year)
- 12.3%
Financial health
- Total cash
- $1.03B
- Total debt
- $1.69B
- Current ratio
- 3.60
- Quick ratio
- 3.25
- Altman Z-Score
- 2.15
- Piotroski F-Score
- 4.00
Dividends
- Dividend yield
- 0.0%
Analysts and estimates
- Average price target
- $200.76
- Median price target
- $200.00
- High price target
- $240.00
- Low price target
- $105.00
- Analysts with a price target
- 25
- Consensus
- Strong buy
- Forward EPS
- -$0.28
- EPS estimate, current year
- -$1.46
Shares and trading
- Beta
- 1.66
- Average volume
- 2.02M
- Shares outstanding
- 135.29M
- Float
- 130.57M
- Institutional ownership
- 98.7%
- Insider ownership
- 4.6%
- Short interest (% of float)
- 7.3%
- Short ratio (days)
- 5.32
